European Medicines Agency appeals Brexit “frustration” ruling

EMA Canary Wharf

The European Medicines Agency (EMA) has appealed the High Court’s ruling that Brexit did not amount to the legal “frustration” of its £500m, 25-year lease with Canary Wharf Group.

The agency was given leave to appeal last month and submitted its appeal just before its deadline on Monday 15 April.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

  • Access up to four FREE articles per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue